Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Humana Inc. buy Guggenheim

Start price
€261.00
09.04.25 / 50%
Target price
€295.52
09.04.26
Performance (%)
-22.72%
Price
€201.70
04.07.25
Summary
This prediction is currently active. The prediction for Humana Inc. disappoints with a performance of -22.72%. This prediction currently runs until 09.04.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction

Humana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.

Performance without dividends (%)
Name 1w 1m
Humana Inc. -2.372% -2.372%
iShares Core DAX® -1.315% -2.266%
iShares Nasdaq 100 0.272% 1.449%
iShares Nikkei 225® -2.496% 1.560%
iShares S&P 500 0.504% 1.340%

Comments by Guggenheim for this prediction

In the thread Humana Inc. diskutieren
Prediction Buy
Perf. (%) -22.72%
Target price 295.519
Change
Ends at 09.04.26

Humana Inc. (NYSE: HUM) is now covered by analysts at Guggenheim. They set a "buy" rating and a $326.00 price target on the stock.
Ratings data for HUM provided by MarketBeat